跳至主要内容
临床试验/NCT00735735
NCT00735735终止不适用

Study of the Measurement of Substance P in the Saliva of Patients With Low Back Pain

Kovacs Foundation2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2009年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
40
试验地点
2
主要终点
Levels of Substance P in the saliva

研究概览

简要总结

The purpose of this study is to compare the levels of Substance P in saliva, in patients with severe chronic low back pain and in subjects without it. In addition, to explore a possible cutoff point, in order to define normal and pathological levels of Substance P in saliva. The ultimate objective would be to design a measurement method for use in routine clinical practice.

研究设计

研究类型
Interventional
干预模型
Parallel
主要目的
Diagnostic
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients referred to the Kovacs Back Pain Unit in Palma de Mallorca for chronic low back pain
  • A pain level of 6 or greater on the PI-NRS scale (0=no pain, 10= worst pain possible)
  • Seen at the Unit between 9 and 13 hours (due to the circadian rhythm of Substance P in saliva and to avoid great variability in the results)
  • For healthy subjects:
  • Volunteers with no pain (anywhere)
  • That in the past year have had no more than 40 days with pain, and no episode of more than 7 days of continuous pain.

排除标准

  • Subjects with pain that is additional to or different from chronic low back pain

结局指标

主要结局

Levels of Substance P in the saliva

时间窗: 12 months

次要结局

未报告次要终点

研究者

发起方
Kovacs Foundation
申办方类型
Other
责任方
Principal Investigator
主要研究者

Francisco M. Kovacs

Director of Scientific Department, Kovacs Foundation

Kovacs Foundation

研究点 (2)

Loading locations...

相似试验